CALL US +44 (0)1462 440 084 | +1 919-882-2016 | Contact | Submit RFI

The Problems (and solutions) of Real World Data in the Pharma Industry

Clinical Programming Team

Our job as Real World Data programmers is to put the whole patient data, usually spread across multiple tables, into one coherent history. This might lead to some surprising discoveries such as: patients with records before birth/after death, patients changing sexes multiple times, and finding non-valid codes. Such discrepancies are usually pretty easy to classify as data issues and are easy to handle. On the other hand we might encounter real world data events that cannot be as easily classified and need special approaches such as; patient receiving multiple Rx’s for the same drug on one day, or receiving a new Rx’s before the previous runs out, patients visiting the Doctor’s office / Emergency Room during their hospital stays, patients changing wards/level of care multiple times during one hospital visit, and finding valid but non-billable codes in insurance claims data. In this post we share some commonly encountered problems (and our solutions) related to Real World Data analysis.

Read More
Topics: Real World Data, Clinical Programming, Observational longitudinal databases, Outcomes Research

Outcomes Research Programming vs Traditional Clinical Trial Programming

Clinical Programming Team

Outcomes research aka health outcomes research, is the study of the end results of particular health care practices and interventions, in other words it is the study of what happens in the real world to patients when they are given a certain treatment or a certain method of care. Outcomes research studies are used to improve the quality and value of healthcare for patients.

Read More
Topics: Statistical Programming, Clinical Study Design, Clinical Programming, Accessible Data, Big Data, Outcomes Research, Real World Data, Teradata SQL, Observation Longitudinal Database

Longitudinal Observational Data in a Paediatric Disease Registry

Statistical Consultancy Team

The use of population-based disease registries to support ongoing data collection for long-term safety and clinical outcomes is becoming increasingly common. Data collection methods within registries can vary in terms of completeness and quality. This particular example arose from support to a post-registration commitment for marketing authorisation of a paediatric drug and aims to provide some insight to the techniques and strategies used to monitor paediatric development (growth, sexual maturation) and clinical outcomes of varying severity. The challenges of accounting for irregular follow-up and associated biases are illustrated, and potential statistical solutions described. Recommendations for future reporting are presented as part of the conclusions. 

Read More
Topics: Statistical Programming, Randomization, Paediatric Disease Registry, Outcomes Research, Real World Data, Observation Longitudinal Database

Welcome to The Quanticate Blog

We aim to provide information and support written by our experienced staff. We want to share our knowledge and create an archive of information that you will be able to engage with, share and comment on.

Subscribe to Email Updates

Blog Suggestions

Most Read

Posts by Topic

Expand all